129 related articles for article (PubMed ID: 3350853)
1. Effectiveness of mitoxantrone on the proliferation of cell cultures derived from malignant mesenchymal tumors of human origin.
Dietel M; Arps H; Gerding D; Trapp M; Sieck M; Niendorf A
J Cancer Res Clin Oncol; 1988; 114(2):197-203. PubMed ID: 3350853
[TBL] [Abstract][Full Text] [Related]
2. The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemia.
Morabito F; Callea I; Console G; Stelitano C; Sculli G; Filangeri M; Oliva B; Musolino C; Iacopino P; Brugiatelli M
Haematologica; 1997; 82(5):560-5. PubMed ID: 9407721
[TBL] [Abstract][Full Text] [Related]
3. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.
Taylor CW; Dalton WS; Parrish PR; Gleason MC; Bellamy WT; Thompson FH; Roe DJ; Trent JM
Br J Cancer; 1991 Jun; 63(6):923-9. PubMed ID: 1676902
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone.
Nielsen D; Eriksen J; Maare C; Litman T; Kjaersgaard E; Plesner T; Friche E; Skovsgaard T
Biochem Pharmacol; 2000 Aug; 60(3):363-70. PubMed ID: 10856431
[TBL] [Abstract][Full Text] [Related]
5. Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone.
Williams LE; Banerji N; Klausner JS; Kapur V; Kanjilal S
Am J Vet Res; 2001 Sep; 62(9):1354-7. PubMed ID: 11560259
[TBL] [Abstract][Full Text] [Related]
6. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
Lim SJ; Cormier JN; Feig BW; Mansfield PF; Benjamin RS; Griffin JR; Chase JL; Pisters PW; Pollock RE; Hunt KK
Ann Surg Oncol; 2007 Aug; 14(8):2309-18. PubMed ID: 17541691
[TBL] [Abstract][Full Text] [Related]
7. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermia-enhanced effectiveness of mitoxantrone in an experimental rat tumour.
Schopman EM; Van Bree C; Bakker PJ; Kipp JB; Barendsen GW
Int J Hyperthermia; 1996; 12(2):241-54. PubMed ID: 8926392
[TBL] [Abstract][Full Text] [Related]
9. Quantitative confocal spectral imaging analysis of mitoxantrone within living K562 cells: intracellular accumulation and distribution of monomers, aggregates, naphtoquinoxaline metabolite, and drug-target complexes.
Feofanov A; Sharonov S; Fleury F; Kudelina I; Nabiev I
Biophys J; 1997 Dec; 73(6):3328-36. PubMed ID: 9414243
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterisation of soft tissue tumor chemosensitivity.
Remmelink M; Salmon I; Delville JP; Goldschmidt D; Capel P; Gebhart M; Pasteels JL; Kiss R; Darro F
Anticancer Res; 1997; 17(3C):2009-17. PubMed ID: 9216658
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin.
Scambia G; De Vincenzo R; Ranelletti FO; Panici PB; Ferrandina G; D'Agostino G; Fattorossi A; Bombardelli E; Mancuso S
Eur J Cancer; 1996 May; 32A(5):877-82. PubMed ID: 9081370
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro.
Hill BT; Hosking LK; Shellard SA; Whelan RD
Cancer Chemother Pharmacol; 1989; 23(3):140-4. PubMed ID: 2924371
[TBL] [Abstract][Full Text] [Related]
13. Chromosome mediated gene transfer of drug resistance to mitoxantrone.
Hazlehurst LA; Gros P; Dalton WS
Anticancer Res; 1998; 18(2A):1005-10. PubMed ID: 9615755
[TBL] [Abstract][Full Text] [Related]
14. Localization and molecular interactions of mitoxantrone within living K562 cells as probed by confocal spectral imaging analysis.
Feofanov A; Sharonov S; Kudelina I; Fleury F; Nabiev I
Biophys J; 1997 Dec; 73(6):3317-27. PubMed ID: 9414242
[TBL] [Abstract][Full Text] [Related]
15. Development of a mitoxantrone-resistant P 388 in vivo: approaches to overcome resistance.
Fichtner I; Becker M; Lemm M; Winterfeld G
Oncology; 1990; 47(6):508-15. PubMed ID: 1700851
[TBL] [Abstract][Full Text] [Related]
16. Biochemical lesions in DNA associated with the antiproliferative effects of mitoxantrone in the hepatoma cell.
Ellis AL; Randolph JK; Conway BR; Gewirtz DA
Biochem Pharmacol; 1990 May; 39(10):1549-56. PubMed ID: 2337411
[TBL] [Abstract][Full Text] [Related]
17. Confocal spectral imaging analysis of intracellular interactions of mitoxantrone at different phases of the cell cycle.
Feofanov A; Charonov S; Fleury F; Kudelina I; Jardillier JC; Nabiev I
Anticancer Res; 1999; 19(6B):5341-8. PubMed ID: 10697559
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
Hida T; Ueda R; Takahashi T; Watanabe H; Kato T; Suyama M; Sugiura T; Ariyoshi Y; Takahashi T
Cancer Res; 1989 Sep; 49(17):4785-90. PubMed ID: 2547517
[TBL] [Abstract][Full Text] [Related]
19. Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.
Bonavida B; Tsuchitani T; Zighelboim J; Berek JS
Gynecol Oncol; 1990 Sep; 38(3):333-9. PubMed ID: 2227544
[TBL] [Abstract][Full Text] [Related]
20. Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells.
Ayash L; Korbut T; Herman TS; Teicher BA
Cancer Lett; 1991 Dec; 61(1):7-14. PubMed ID: 1764699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
